Form 4: Datadog CFO David Obstler Executes Stock Option and Sells Shares
SEC Form 4 Filing
Datadog's Chief Financial Officer, David Obstler, exercised stock options and sold shares of Class A Common Stock on October 11, 2024, according to a recent SEC filing.
Summary
- On October 11, 2024, David Obstler, the Chief Financial Officer of Datadog, Inc., engaged in transactions involving the company's stock.
- Obstler exercised a stock option to acquire 33,333 shares of Class A Common Stock at a price of $1.55 per share.
- Concurrently, Obstler sold 33,333 shares of Class A Common Stock at a weighted-average price of $130.3915 per share, with prices ranging from $130.25 to $130.59.
- Following these transactions, Obstler directly owns 314,158 shares of Class A Common Stock.
- Obstler also indirectly owns 92,397 shares of Class A Common Stock through the Obstler Children 2019 Trust.
- The sale was executed pursuant to a pre-arranged 10b5-1 trading plan established on June 12, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a standard disclosure of insider trading activity. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, often under pre-arranged trading plans like the 10b5-1 plan, to manage their personal finances.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly traded companies.
- The use of 10b5-1 trading plans is a standard practice to avoid accusations of insider trading, aligning with regulations and best practices observed across similar tech companies like Snowflake (SNOW) and CrowdStrike (CRWD).
- The size and frequency of these transactions are typical for executives at Datadog's stage and market capitalization.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a key executive, but the existence of a 10b5-1 plan mitigates concerns about opportunistic trading.
- Employees are unlikely to be significantly affected by this transaction.
Key Dates
| Date | Description |
|---|---|
| June 12, 2024 | Date of 10b5-1 plan adoption |
| October 11, 2024 | Date of stock option exercise and sale of shares |
| October 16, 2024 | Date of signature on the SEC filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.